TABLE OF CONTENTS
|  | | | | Volume 23, Issue 2 (February 2018) |  | In this issue
 Image
News and Commentary
Perspective
Review
Original Articles
Corrigendum
Erratum
Also new
   AOP
| | | | | Image | | | Synaptic mechanism in Alzheimer's disease: a selective degeneration of an excitatory synaptic pathway in the CA1 hippocampus that controls spatial learning and memory in Alzheimer's disease X Yang, C Yao, T Tian, X Li, H Yan et al. Molecular Psychiatry 2018 23 :167 - 167; January 26, 2018; 10.1038/mp.2018.1 Abstract | Full Text | | News and Commentary | | |  | Polygenic prediction of obsessive compulsive symptoms N R Zilhão, A Abdellaoui, D J A Smit, D C Cath, J J Hottenga et al. Molecular Psychiatry 2017 23 :168 - 169; December 05, 2017; 10.1038/mp.2017.248 Abstract | Full Text | | Perspective | | | Trained innate immunity: a salient factor in the pathogenesis of neuroimmune psychiatric disorders A P Salam, A Borsini & P A Zunszain Molecular Psychiatry 2017 23 :170 - 176; December 12, 2017; 10.1038/mp.2017.186 Abstract | Full Text | | Review | | | Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review Molecular Psychiatry 2017 23 :177 - 198; December 12, 2017; 10.1038/mp.2017.246 Abstract | Full Text | | Original Articles | | | A novel mechanism of memory loss in Alzheimer's disease mice via the degeneration of entorhinal–CA1 synapses X Yang, C Yao, T Tian, X Li, H Yan et al. Molecular Psychiatry 2016 23 :199 - 210; September 27, 2016; 10.1038/mp.2016.151 Abstract | Full Text | | | | | Blockade of the KATP channel Kir6.2 by memantine represents a novel mechanism relevant to Alzheimer's disease therapy S Moriguchi, T Ishizuka, Y Yabuki, N Shioda, Y Sasaki et al. Molecular Psychiatry 2016 23 :211 - 221; October 25, 2016; 10.1038/mp.2016.187 Abstract | Full Text | | | | | De novo and inherited mutations in the X-linked gene CLCN4 are associated with syndromic intellectual disability and behavior and seizure disorders in males and females E E Palmer, T Stuhlmann, S Weinert, E Haan, H Van Esch et al. Molecular Psychiatry 2016 23 :222 - 230; August 23, 2016; 10.1038/mp.2016.135 Abstract | Full Text | | | | | Association of rare missense variants in the second intracellular loop of NaV1.7 sodium channels with familial autism M Rubinstein, A Patowary, I B Stanaway, E McCord, R R Nesbitt et al. Molecular Psychiatry 2016 23 :231 - 239; December 13, 2016; 10.1038/mp.2016.222 Abstract | Full Text | | | | | Gestational vitamin D deficiency and autism-related traits: the Generation R Study A A E Vinkhuyzen, D W Eyles, T H J Burne, L M E Blanken, C J Kruithof et al. Molecular Psychiatry 2016 23 :240 - 246; November 29, 2016; 10.1038/mp.2016.213 Abstract | Full Text | | | | | Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial R E Frye, J Slattery, L Delhey, B Furgerson, T Strickland et al. Molecular Psychiatry 2016 23 :247 - 256; October 18, 2016; 10.1038/mp.2016.168 Abstract | Full Text | | | | | The familial co-aggregation of ASD and ADHD: a register-based cohort study L Ghirardi, I Brikell, R Kuja-Halkola, C M Freitag, B Franke et al. Molecular Psychiatry 2017 23 :257 - 262; February 28, 2017; 10.1038/mp.2017.17 Abstract | Full Text | | | | | ASD and schizophrenia show distinct developmental profiles in common genetic overlap with population-based social communication difficulties B St Pourcain, E B Robinson, V Anttila, B B Sullivan, J Maller et al. Molecular Psychiatry 2017 23 :263 - 270; January 03, 2017; 10.1038/mp.2016.198 Abstract | Full Text | | | | | Inhibition of STEP61 ameliorates deficits in mouse and hiPSC-based schizophrenia models J Xu, B J Hartley, P Kurup, A Phillips, A Topol et al. Molecular Psychiatry 2016 23 :271 - 281; October 18, 2016; 10.1038/mp.2016.163 Abstract | Full Text | | | | | Prenatal one-carbon metabolism dysregulation programs schizophrenia-like deficits A Alachkar, L Wang, R Yoshimura, A R Hamzeh, Z Wang et al. Molecular Psychiatry 2017 23 :282 - 294; August 15, 2017; 10.1038/mp.2017.164 Abstract | Full Text | | | | | Changed gene expression in subjects with schizophrenia and low cortical muscarinic M1 receptors predicts disrupted upstream pathways interacting with that receptor E Scarr, M Udawela, E A Thomas & B Dean Molecular Psychiatry 2016 23 :295 - 303; November 01, 2016; 10.1038/mp.2016.195 Abstract | Full Text | | | | | The schizophrenia- and autism-associated gene, transcription factor 4 regulates the columnar distribution of layer 2/3 prefrontal pyramidal neurons in an activity-dependent manner S C Page, G R Hamersky, R A Gallo, M D Rannals, N E Calcaterra et al. Molecular Psychiatry 2017 23 :304 - 315; March 14, 2017; 10.1038/mp.2017.37 Abstract | Full Text | | | | | Biochemical, physiological and clinical effects of l-methylfolate in schizophrenia: a randomized controlled trial J L Roffman, L J Petruzzi, A S Tanner, H E Brown, H Eryilmaz et al. Molecular Psychiatry 2017 23 :316 - 322; March 14, 2017; 10.1038/mp.2017.41 Abstract | Full Text | | | | | Translational evaluation of translocator protein as a marker of neuroinflammation in schizophrenia T Notter, J M Coughlin, T Gschwind, U Weber-Stadlbauer, Y Wang et al. Molecular Psychiatry 2017 23 :323 - 334; January 17, 2017; 10.1038/mp.2016.248 Abstract | Full Text | | | | | Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions Molecular Psychiatry 2016 23 :335 - 343; October 18, 2016; 10.1038/mp.2016.167 Abstract | Full Text | | | | | Lipocalin-2 protects the brain during inflammatory conditions S S Kang, Y Ren, C-C Liu, A Kurti, K E Baker et al. Molecular Psychiatry 2017 23 :344 - 350; January 10, 2017; 10.1038/mp.2016.243 Abstract | Full Text | | | | | Cafeteria diet and probiotic therapy: cross talk among memory, neuroplasticity, serotonin receptors and gut microbiota in the rat J E Beilharz, N O Kaakoush, J Maniam & M J Morris Molecular Psychiatry 2017 23 :351 - 361; March 14, 2017; 10.1038/mp.2017.38 Abstract | Full Text | | | | | JNK1 controls adult hippocampal neurogenesis and imposes cell-autonomous control of anxiety behaviour from the neurogenic niche H Mohammad, F Marchisella, S Ortega-Martinez, P Hollos, K Eerola et al. Molecular Psychiatry 2016 23 :362 - 374; November 15, 2016; 10.1038/mp.2016.203 Abstract | Full Text | | | | | Evidence for neuroplastic compensation in the cerebral cortex of persons with depressive illness R Bansal, D J Hellerstein & B S Peterson Molecular Psychiatry 2017 23 :375 - 383; March 07, 2017; 10.1038/mp.2017.34 Abstract | Full Text | | | | | Identification of a novel, fast-acting GABAergic antidepressant K M J McMurray, M J Ramaker, A M Barkley-Levenson, P S Sidhu, P K Elkin et al. Molecular Psychiatry 2017 23 :384 - 391; March 21, 2017; 10.1038/mp.2017.14 Abstract | Full Text | | | | | Peripheral administration of lactate produces antidepressant-like effects A Carrard, M Elsayed, M Margineanu, B Boury-Jamot, L Fragnière et al. Molecular Psychiatry 2016 23 :392 - 399; October 18, 2016; 10.1038/mp.2016.179 Abstract | Full Text | | | | | The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders H Chang, N Hoshina, C Zhang, Y Ma, H Cao et al. Molecular Psychiatry 2017 23 :400 - 412; January 10, 2017; 10.1038/mp.2016.231 Abstract | Full Text | | | | | Structural dysconnectivity of key cognitive and emotional hubs in young people at high genetic risk for bipolar disorder G Roberts, A Perry, A Lord, A Frankland, V Leung et al. Molecular Psychiatry 2016 23 :413 - 421; December 20, 2016; 10.1038/mp.2016.216 Abstract | Full Text | | | | | A DNA methylation biomarker of alcohol consumption C Liu, R E Marioni, Å K Hedman, L Pfeiffer, P-C Tsai et al. Molecular Psychiatry 2016 23 :422 - 433; November 15, 2016; 10.1038/mp.2016.192 Abstract | Full Text | | | | | In silico identification and in vivo validation of miR-495 as a novel regulator of motivation for cocaine that targets multiple addiction-related networks in the nucleus accumbens R M Bastle, R J Oliver, A S Gardiner, N S Pentkowski, F Bolognani et al. Molecular Psychiatry 2017 23 :434 - 443; January 03, 2017; 10.1038/mp.2016.238 Abstract | Full Text | | | | | OCD-like behavior is caused by dysfunction of thalamo-amygdala circuits and upregulated TrkB/ERK-MAPK signaling as a result of SPRED2 deficiency M Ullrich, M Weber, A M Post, S Popp, J Grein et al. Molecular Psychiatry 2017 23 :444 - 458; January 10, 2017; 10.1038/mp.2016.232 Abstract | Full Text | | | | | Brain structural and functional signatures of impulsive–compulsive behaviours in Parkinson's disease F Imperiale, F Agosta, E Canu, V Markovic, A Inuggi et al. Molecular Psychiatry 2017 23 :459 - 466; March 07, 2017; 10.1038/mp.2017.18 Abstract | Full Text | | | | | DIXDC1 contributes to psychiatric susceptibility by regulating dendritic spine and glutamatergic synapse density via GSK3 and Wnt/ß-catenin signaling P-M Martin, R E Stanley, A P Ross, A E Freitas, C E Moyer et al. Molecular Psychiatry 2016 23 :467 - 475; October 18, 2016; 10.1038/mp.2016.184 Abstract | Full Text | | | | | OTTO: a new strategy to extract mental disease-relevant combinations of GWAS hits from individuals H Ehrenreich, M Mitjans, S Van der Auwera, T P Centeno, M Begemann et al. Molecular Psychiatry 2016 23 :476 - 486; December 06, 2016; 10.1038/mp.2016.208 Abstract | Full Text | | Corrigendum | | | JNK1 controls adult hippocampal neurogenesis and imposes cell-autonomous control of anxiety behaviour from the neurogenic niche H Mohammad, F Marchisella, S Ortega-Martinez, P Hollos, K Eerola et al. Molecular Psychiatry 2017 23 :487 - 487; February 14, 2017; 10.1038/mp.2017.21 Abstract | Full Text | | Erratum | | | Peripheral administration of lactate produces antidepressant-like effects A Carrard, M Elsayed, M Margineanu, B Boury-Jamot, L Fragnière et al. Molecular Psychiatry 2016 23 :488 - 488; December 06, 2016; 10.1038/mp.2016.237 Abstract | Full Text | |  | | | | | | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com | | | | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Molecular Psychiatry. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved. |  | | | |
No comments:
Post a Comment